LEXAGNE HOLDINGS WKN: A2ATW9 ISIN: CA52886L1031 Kürzel: 5XS2 Forum: Aktien Thema: Hauptdiskussion

Dr. Jack Regan, LexaGene’s CEO and Founder states, “Early in my career, I helped develop the Autonomous Pathogen Detection System (APDS), which was selected by the U.S. Department of Homeland Security to be the first autonomous detector component of their BioWatch antiterrorism program 👌👌👍👍

Scheint den Kurs absolut nicht zu interessieren 🙈

https://www.globenewswire.com/news-release/2021/09/16/2298338/0/en/LexaGene-Enters-into-Cooperative-Research-and-Development-Agreement-with-the-United-States-Army-s-Combat-Capabilities-Development-Command.html

https://www.streetinsider.com/dr/news.php?id=18903503

Und wieder sind wir auf Start zurück!

https://www.globenewswire.com/news-release/2021/08/12/2279688/0/en/LexaGene-Demonstrates-a-Simple-and-Inexpensive-Multiplex-PCR-Chemistry-with-Shorter-Lead-Times-for-use-on-its-MiQLab-System.html

wo bleiben die seit einem jahr versprochenen verkäufe des gerätes?alles ****

https://www.globenewswire.com/news-release/2021/07/20/2265550/0/en/LexaGene-s-MiQLab-Detects-Common-Bioreactor-Contaminant-up-to-300-Times-Faster-than-Conventional-Methods.html

.....ist wenn FDA und EUA Approval für Human kommt. Damit ganz anderer Sales Ausblick ....dann!

Irgendwann.......

LexaGene Launches 2nd Generation Bacterial and Drug Resistance Test to Better Meet the Diagnostic Needs of Veterinarians https://www.globenewswire.com/news-release/2021/07/07/2258874/0/en/LexaGene-Launches-2nd-Generation-Bacterial-and-Drug-Resistance-Test-to-Better-Meet-the-Diagnostic-Needs-of-Veterinarians.html